申请人:John Wyeth & Brother Limited
公开号:US04360519A1
公开(公告)日:1982-11-23
Morpholine derivatives of the formula ##STR1## and their pharmaceutically acceptable acid addition salts[wherein R.sup.1 represents lower alkyl. R.sup.2 represents hydrogen, lower alkyl, benzyl, lower alkoxymethyl or an acyl group; R.sup.3 represents hydrogen, lower alkyl or phenyl; R.sup.4, R.sup.5 and R.sup.6 are independently hydrogen or lower alkyl and R.sup.7 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, aryl(lower)alkyl, tetrahydrofurylmethyl or cycloalkylmethyl] possess analgesic and/or opiate antagonistic activity.
式子为##STR1##的吗啡啶衍生物及其药学上可接受的酸盐[其中,R.sup.1代表低碳基;R.sup.2代表氢、低碳基、苯甲基、低碳氧甲基或酰基;R.sup.3代表氢、低碳基或苯基;R.sup.4、R.sup.5和R.sup.6独立地代表氢或低碳基,R.sup.7代表氢、低碳基、低烯基、低炔基、芳基(低)烷基、四氢呋喃基甲基或环烷基甲基]具有镇痛和/或阿片受体拮抗活性。